Alterola Biotech Pink Sheet Forecast - Simple Exponential Smoothing
| ABTI Stock | USD 0.01 0.00 0.00% |
The Simple Exponential Smoothing forecasted value of Alterola Biotech on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.0001 and the sum of the absolute errors of 0.01. Alterola Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Alterola Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the relative strength index (rsi) of Alterola Biotech's share price is below 20 . This suggests that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Alterola Biotech hype-based prediction, you can estimate the value of Alterola Biotech from the perspective of Alterola Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Alterola Biotech on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.0001 and the sum of the absolute errors of 0.01. Alterola Biotech after-hype prediction price | USD 0.005409 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Alterola |
Alterola Biotech Additional Predictive Modules
Most predictive techniques to examine Alterola price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alterola using various technical indicators. When you analyze Alterola charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Alterola Biotech Simple Exponential Smoothing Price Forecast For the 24th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Alterola Biotech on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.0001, mean absolute percentage error of 0.00000069, and the sum of the absolute errors of 0.01.Please note that although there have been many attempts to predict Alterola Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Alterola Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Alterola Biotech Pink Sheet Forecast Pattern
| Backtest Alterola Biotech | Alterola Biotech Price Prediction | Buy or Sell Advice |
Alterola Biotech Forecasted Value
In the context of forecasting Alterola Biotech's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Alterola Biotech's downside and upside margins for the forecasting period are 0.000051 and 126.07, respectively. We have considered Alterola Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Alterola Biotech pink sheet data series using in forecasting. Note that when a statistical model is used to represent Alterola Biotech pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 102.0921 |
| Bias | Arithmetic mean of the errors | -1.0E-4 |
| MAD | Mean absolute deviation | 1.0E-4 |
| MAPE | Mean absolute percentage error | 0.0207 |
| SAE | Sum of the absolute errors | 0.0077 |
Predictive Modules for Alterola Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alterola Biotech. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alterola Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alterola Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Alterola Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alterola Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Alterola Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Alterola Biotech Estimiated After-Hype Price Volatility
In the context of predicting Alterola Biotech's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alterola Biotech's historical news coverage. Alterola Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 50.26, respectively. We have considered Alterola Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Alterola Biotech is out of control at this time. Analysis and calculation of next after-hype price of Alterola Biotech is based on 3 months time horizon.
Alterola Biotech Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Alterola Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alterola Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alterola Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
15.53 | 126.06 | 0.00 | 1.48 | 0 Events / Month | 4 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 6.05 |
|
Alterola Biotech Hype Timeline
Alterola Biotech is presently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 1.48. Alterola is anticipated to increase in value after the next headline, with the price projected to jump to 0.005409 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is estimated to be 6.05%, whereas the daily expected return is presently at 15.53%. The volatility of related hype on Alterola Biotech is about 132694.74%, with the expected price after the next announcement by competition of 1.49. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Alterola Biotech to cross-verify your projections.Alterola Biotech Related Hype Analysis
Having access to credible news sources related to Alterola Biotech's direct competition is more important than ever and may enhance your ability to predict Alterola Biotech's future price movements. Getting to know how Alterola Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alterola Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BHHKF | Benchmark Botanics | (0.14) | 4 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CPHRF | Cipher Pharmaceuticals | 0.00 | 0 per month | 1.99 | (0.02) | 3.83 | (2.33) | 11.28 | |
| ONVVF | Oneview Healthcare PLC | 0.00 | 0 per month | 0.00 | 0.06 | 0.00 | 0.00 | 210.00 | |
| BHCCF | Benchmark Holdings plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EDTXF | Spectral Med | (0.14) | 18 per month | 0.00 | (0.08) | 5.62 | (4.85) | 22.77 | |
| NIKA | Nika BioTechnology | 0.00 | 0 per month | 0.00 | 0.05 | 0.00 | 0.00 | 35.71 | |
| DMTRF | 3 D Matrix | 0.00 | 0 per month | 0.00 | 0.15 | 0.00 | 0.00 | 27.33 | |
| MAYNF | Mayne Pharma Group | 0.51 | 10 per month | 0.00 | (0.12) | 8.63 | (9.75) | 46.83 | |
| IDGXF | Integrated Diagnostics Holdings | 0.21 | 42 per month | 0.00 | 0.09 | 0.00 | 0.00 | 30.53 | |
| CMVLF | Cellectis SA | 0.51 | 3 per month | 0.00 | (0.22) | 0.00 | 0.00 | 10.71 |
Other Forecasting Options for Alterola Biotech
For every potential investor in Alterola, whether a beginner or expert, Alterola Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Alterola Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Alterola. Basic forecasting techniques help filter out the noise by identifying Alterola Biotech's price trends.Alterola Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterola Biotech pink sheet to make a market-neutral strategy. Peer analysis of Alterola Biotech could also be used in its relative valuation, which is a method of valuing Alterola Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Alterola Biotech Market Strength Events
Market strength indicators help investors to evaluate how Alterola Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alterola Biotech shares will generate the highest return on investment. By undertsting and applying Alterola Biotech pink sheet market strength indicators, traders can identify Alterola Biotech entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0051 | |||
| Day Typical Price | 0.0051 |
Alterola Biotech Risk Indicators
The analysis of Alterola Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alterola Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alterola pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 94.02 | |||
| Standard Deviation | 387.79 | |||
| Variance | 150379.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Alterola Biotech
The number of cover stories for Alterola Biotech depends on current market conditions and Alterola Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alterola Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alterola Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Alterola Biotech Short Properties
Alterola Biotech's future price predictability will typically decrease when Alterola Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alterola Biotech often depends not only on the future outlook of the potential Alterola Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alterola Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 770 M | |
| Shares Float | 163.6 M |
Other Information on Investing in Alterola Pink Sheet
Alterola Biotech financial ratios help investors to determine whether Alterola Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterola with respect to the benefits of owning Alterola Biotech security.